$38,965,983

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

healthactiveONGOING · MOD OF 2020 CONTRACT

WORK BEGAN2020-09-28·LATEST ACTION2026-05-08·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50120C00171_7505_-NONE-_-NONE-

Award description

INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Obligation on the 2020 mustard gas keratopathy treatment program; advancing clinical protocols for chemical weapons exposure casualties.

Sub-sectors

chemical-weapons-treatmentemergency-preparednessclinical-research

Why this matters

Prepares U.S. medical system to treat chemical weapons casualties; core to DOD CBRN defense infrastructure.

Supply-chain signal

Supports pharmaceutical and medical device suppliers developing ophthalmologic treatments and chemical exposure countermeasures.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-14. Cost: $0.018338.

Period of performance

Start

2020-09-28

End

2028-11-16

Status

activein 855 days

Recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50120C00171_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.